Skip to main content
padlock icon - secure page this page is secure

Publisher: Wiley-Blackwell

Volume 94, Number 7, 1 July 2019

Ibrutinib and idelalisib in the management of CLL‐associated autoimmune cytopenias: a study from the FILO group
pp. E183-E185(3)
Authors: Quinquenel, Anne; Godet, Sophie; Dartigeas, Caroline; Ysebaert, Loïc; Dupuis, Jehan; Ohanyan, Haykanush; Collignon, Aude; Gilardin, Laurent; Lepretre, Stéphane; Dilhuydy, Marie‐Sarah; Vignon, Marguerite; Guibert, Sophie; Dmytruk, Natalia; Durot, Eric; Ghez, David; Roos Weil, Damien; Béné, Marie‐Christine; Toussaint, Elise; Merabet, Fatiha; Lévy, Vincent; Delmer, Alain; Aurran, Thérèse

Favourites:
ADD

Ruxolitinib treatment and risk of B‐cell lymphomas in myeloproliferative neoplasms
pp. E185-E188(4)
Authors: Rumi, Elisa; Zibellini, Silvia; Boveri, Emanuela; Cavalloni, Chiara; Riboni, Roberta; Casetti, Ilaria Carola; Ciboddo, Michele; Trotti, Chiara; Favaron, Cristina; Pietra, Daniela; Candido, Chiara; Ferretti, Virginia Valeria; Cazzola, Mario; Arcaini, Luca

Favourites:
ADD

Intensive chemotherapy is more effective than hypomethylating agents for the treatment of younger patients with myelodysplastic syndrome and elevated bone marrow blasts
pp. E188-E190(3)
Authors: Strati, Paolo; Garcia‐Manero, Guillermo; Zhao, Chong; Kadia, Tapan; Borthakur, Gautam; Konopleva, Marina; Daver, Naval; DiNardo, Courtney D.; Short, Nicholas J.; Yilmaz, Musa; Naqvi, Kiran; Alvarado, Yesid; Pierce, Sherry A.; Cortes, Jorge; Bueso‐Ramos, Carlos; Kantarjian, Hagop; Ravandi, Farhad

Favourites:
ADD

Prognostic significance of upfront radiation therapy in patients with multiple myeloma
pp. E190-E194(5)
Authors: Orcutt, Xavier; Barth, Peter; Olszewski, Adam J.

Favourites:
ADD

Optimizing thiopurine dosing based on TPMT and NUDT15 genotypes: It takes two to tango
pp. 737-740(4)
Authors: Koutsilieri, Stefania; Caudle, Kelly E.; Alzghari, Saeed Khaled; Monte, Andrew A.; Relling, Mary V.; Patrinos, George P.

Favourites:
ADD

Second‐line treatments in children with immune thrombocytopenia: Effect on platelet count and patient‐centered outcomes
pp. 741-750(10)
Authors: Grace, Rachael F.; Shimano, Kristin A.; Bhat, Rukhmi; Neunert, Cindy; Bussel, James B.; Klaassen, Robert J.; Lambert, Michele P.; Rothman, Jennifer A.; Breakey, Vicky R.; Hege, Kerry; Bennett, Carolyn M.; Rose, Melissa J.; Haley, Kristina M.; Buchanan, George R.; Geddis, Amy; Lorenzana, Adonis; Jeng, Michael; Pastore, Yves D.; Crary, Shelley E.; Neier, Michelle; Neufeld, Ellis J.; Neu, Nolan; Forbes, Peter W.; Despotovic, Jenny M.

Favourites:
ADD

Prognostic value of minimal residual disease and polyclonal plasma cells in myeloma patients achieving a complete response to therapy
pp. 751-756(6)
Authors: Tschautscher, Marcella A.; Jevremovic, Dragan; Rajkumar, Vincent; Dispenzieri, Angela; Lacy, Martha Q.; Gertz, Morie A.; Buadi, Francis K.; Dingli, David; Hwa, Yi L.; Fonder, Amie L.; Hobbs, Miriam A.; Hayman, Suzanne R.; Zeldenrust, Steven R.; Lust, John A.; Russell, Stephen J.; Leung, Nelson; Kapoor, Prashant; Go, Ronald S.; Lin, Yi; Gonsalves, Wilson I.; Kourelis, Taxiarchis; Warsame, Rahma; Kyle, Robert A.; Kumar, Shaji K.

Favourites:
ADD

DDX41 mutations in myeloid neoplasms are associated with male gender, TP53 mutations and high‐risk disease
pp. 757-766(10)
Authors: Quesada, Andrés E.; Routbort, Mark J.; DiNardo, Courtney D.; Bueso‐Ramos, Carlos E.; Kanagal‐Shamanna, Rashmi; Khoury, Joseph D.; Thakral, Beenu; Zuo, Zhuang; Yin, C. Cameron; Loghavi, Sanam; Ok, Chi Y.; Wang, Sa A.; Tang, Zhenya; Bannon, Sarah A.; Benton, Christopher B.; Garcia‐Manero, Guillermo; Kantarjian, Hagop; Luthra, Rajyalakshmi; Medeiros, L. Jeffrey; Patel, Keyur P.

Favourites:
ADD

Suboptimal response rates to hypomethylating agent therapy in chronic myelomonocytic leukemia; a single institutional study of 121 patients
pp. 767-779(13)
Authors: Coston, Tucker; Pophali, Prateek; Vallapureddy, Rangit; Lasho, Terra L.; Finke, Christy M.; Ketterling, Rhett P.; Carr, Ryan; Binder, Moritz; Mangaonkar, Abhishek A.; Gangat, Naseema; Al‐Kali, Aref; Litzow, Mark; Zblewski, Darci; Pardanani, Animesh; Tefferi, Ayalew; Patnaik, Mrinal M.

Favourites:
ADD

Bleeding incidence and risk factors among cancer patients treated with anticoagulation
pp. 780-785(6)
Authors: Angelini, Dana E.; Radivoyevitch, Tomas; McCrae, Keith R.; Khorana, Alok A.

Favourites:
ADD

Detection of extranodal and spleen involvement by FDG‐PET imaging predicts adverse survival in untreated follicular lymphoma
pp. 786-793(8)
Authors: St‐Pierre, Frédérique; Broski, Stephen M.; LaPlant, Betsy R.; Ristow, Kay; Maurer, Matthew J.; Macon, William R.; Habermann, Thomas M.; Ansell, Stephen M.; Thompson, Carrie A.; Micallef, Ivana N. M.; Nowakowski, Grzegorz S.; Witzig, Thomas E.

Favourites:
ADD

Weekly carfilzomib, lenalidomide, and dexamethasone in relapsed or refractory multiple myeloma: A phase 1b study
pp. 794-802(9)
Authors: Biran, Noa; Siegel, David; Berdeja, Jesus G.; Raje, Noopur; Cornell, Robert Frank; Alsina, Melissa; Kovacsovics, Tibor; Fang, Belle; Kimball, Amy S.; Landgren, Ola

Favourites:
ADD

Optimizing survival outcomes with post‐remission therapy in acute myeloid leukemia
pp. 803-811(9)
Authors: Medeiros, Bruno C.; Chan, Steven M.; Daver, Naval G.; Jonas, Brian A.; Pollyea, Daniel A.

Favourites:
ADD
Favourites:
ADD

Splenic rupture in cytomegalovirus infection
pp. 828-829(2)
Authors: Farnell, Rachel; Siow, Wenchee; Bain, Barbara J.

Favourites:
ADD

Immune neutropenia mediated by micafungin
pp. 830-832(3)
Authors: Ameri, Amir H.; Curtis, Brian R.; Sykes, David B.

Favourites:
ADD

The D‐dimer assay
pp. 833-839(7)
Authors: Johnson, Eric D.; Schell, John C.; Rodgers, George M.

Favourites:
ADD

Concomitant classic Hodgkin lymphoma and schistosomiasis
pp. 840-841(2)
Authors: Wong, Waihay J.; Ruhangaza, Deogratias; Manirakiza, Alexis; Omondi, Jack; Mugabe, Marcellin C.; Isabelle, Izimukwiye; Morgan, Elizabeth A.; Aster, Jon C.

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more